Immune-related adverse events
| Toxicity | N (%) | ||
| Total (n=90) | Male (n=51) | Female (n=39) | |
| Skin/rash | 34 (37.8) | 18 (35.3) | 16 (41.0) |
| Endocrine | 24 (26.7) | 12 (23.5) | 12 (31.0) |
| Hypothyroidism | 18 (20.0) | 8 (15.7) | 10 (25.6) |
| Hypophysitis | 10 (11.1) | 5 (9.8) | 5 (12.8) |
| Colitis | 24 (26.7) | 16 (31.4) | 8 (21.0) |
| Hepatitis | 15 (16.7) | 10 (20.0) | 5 (12.8) |
| Pulmonary | 8 (8.9) | 4 (7.8) | 4 (10.3) |
| Neuro | 7 (7.8) | 6 (11.8) | 1 (2.6) |
| Musculoskeletal | 6 (6.7) | 1 (2.0) | 5 (12.8) |
| Cardiac | 1 (1.1) | 0 (0.0) | 1 (2.6) |
| Renal | 1 (1.1) | 1 (2.0) | 0 (0.0) |
| Other | 13 (14.4) | 6 (11.8) | 7 (18.0) |